Asthma research and practice: a new journey begins

Juan Carlos Ivancevich Wednesday, 10 June 2015 15:47

Juan C. Celedon1*Giovanni Passalacqua2 and Giorgio Walter Canonica2

  • *Corresponding author: Juan C Celedon This email address is being protected from spambots. You need JavaScript enabled to view it.

Author Affiliations

1Division of Pediatric Pulmonary Medicine, Allergy and Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania

2Allergy and Respiratory Diseases, Department of Internal Medicine, IRCCS San Martino Hospital-IST-University of Genoa, Genova, Italy

For all author emails, please log on.

Asthma Research and Practice 2015, 1:5  doi:10.1186/s40733-015-0005-3

The electronic version of this article is the complete one and can be found online at:Missingcontent/1/1/5

© 2015 Celedon et al.; licensee BioMed Central. 

Editorial

As co-Editors in Chief (and Professor Canonica as President of Interasma), it is our pleasure to welcome our colleagues to this first issue of the journal Asthma Research and Practice (ARP[1]. This will be an open-access online journal, and thus easily accessible to a large audience. The aims and scope of ARP will be to publish original research articles and state of the art reviews focusing on risk factors, diagnosis and management of asthma at all ages. Since asthma is a disease that comprises diverse endotypes and is often accompanied by co-morbidities, we expect and welcome manuscripts on topics such as “obese asthma”, exercise-induced asthma, asthma-COPD overlap syndrome, occupational asthma, and others [2], [3]. Although existing journals in fields as diverse as paediatrics, internal medicine, allergy and pulmonology include articles on asthma, we believe that a journal entirely dedicated to asthma is both valuable and necessary. Moreover, we are committed to have a section devoted entirely to pediatric asthma, one of the most common chronic diseases of childhood in industrialized nations.

The title of this new journal include the word “practice” to emphasize our explicit intent to address practical aspects of asthma diagnosis and management, which are of greatest interest to the physicians and health care professionals caring for millions of children and adults with asthma worldwide. Thus, the Editors and the Editorial Board of ARP are committed to link mechanistic and practical knowledge of asthma in future years. We want to emphasize the strict cooperation between the Journal and Interasma [4]. This latter organization, founded in 1954 and currently chaired by Prof. G.W. Canonica, has the main missions of bridging the gaps between academy and clinical practice and of establishing an interdisciplinary forum on asthma worldwide. Notably, this mission is largely in agreement with that of ARP.

All manuscripts submitted to ARP will undergo a thorough peer-review process by physicians and scientists with relevant expertise. The Editorial Board [5] of ARP is committed to ensure a fair but reasonably expeditious peer-review process, followed by immediate online publication of accepted manuscripts as free articles, which will be accessible in PubMed. The Editors and the Editorial Board further commit and expect that ARP will rapidly get an Impact Factor that reflects the quality and value of this journal.

We would like to express our profound gratitude to our dear colleague and friend, Professor Carlos Baena-Cagnani. Carlos conceived and enthusiastically supported the preparation and launching of this journal, which is and will always be a tribute to his memory.

The first publications in ARP include two original research articles and a comprehensive review. The first article reports the findings of a Phase I clinical trial of vitamin D supplementation in patients with cystic fibrosis and allergic bronchopulmonary aspergillosis (ABPA), a condition that causes significant morbidity in patients with asthma [6]. Although preliminary by design, this Phase I trial demonstrates the efficacy of the tested dose of vitamin D (4,000 IU/day) in both achieving vitamin D sufficiency and reducing Th2 immune responses relevant to ABPA and other allergic conditions such as asthma. The second article reports the findings of an Italian questionnaire-based survey about respiratory allergy, as described by patients referred to pharmacists for their symptoms [7]. This aspect is of special interest, since pharmacists are usually the first-line referral. The Authors found that 11 % of patients who accessed pharmacies had only lower respiratory symptoms, but that a large fraction of the population had co-existing upper and lower respiratory symptoms. Notably, about 50 % of patients had not received a medical diagnosis, and thus self-management of repiratory symptoms was common. In spite of the limitations of the questionnaire-based design, those findings highlight the problems of under-diagnosis and under-treatment. The third article reviews current literature on the increasingly common “obese asthma” phenotype, including potential causes, modifiers and common co-morbidities; impact of overweight or obesity on asthma control; growing evidence of distinct endotypes of “obese asthma”; and treatment of patients with co-existing obesity and asthma[8].

We conclude by inviting all of our esteemed colleagues to submit their work to Asthma Research and Practice, while also welcoming their suggestions to improve the quality and reach of the journal.

Competing interests

The authors declare that they have no competing interests.

References

  1. Asthma Research and Practice. http://www.asthmarp.com. Accessed 29 May 2015.

  2. Asher MI, Stewart AW, Mallol J, Montefort S, Lai CK, Aït-Khaled N, Odhiambo J. Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase OneRespir Res. 2010; 11:8. PubMed Abstract | BioMed Central Full Text OpenURL

  3. Papaiwannou A, Zarogoulidis P, Porpodis K, Spyratos D, Kioumis I, Pitsiou G, Pataka A, Tsakiridis K, Arikas S, Mpakas A, Tsiouda T, Katsikogiannis N, Kougioumtzi I, Machairiotis N, Siminelakis S, Kolettas A, Kessis G, Beleveslis T, Zarogoulidis K. Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature reviewJ Thorac Dis. 2014; 6 Suppl 1:S146-51. PubMed Abstract | Publisher Full Text OpenURL

  4. Interasma. http://www.interasma.org. Accessed 29 May 2015.

  5. Asthma Research and Practice: Editorial Board. http://www.asthmarp.com/about/edboard. Accessed 29 May 2015.

  6. Nguyen N, Pilewski JM, Celdon JC, Mandalapu S, Blanchard ML, DeRicco A, et al. Vitamin D Supplementation Decreases Aspergillus fumigatus Specific Th2 Responses in CF Patients with Aspergillus sensitization: A Phase One Open-Label Study. Asthma Res Pract. doi:10.1186/s40733-015-0003-5.

  7. Lombardi CP. The patient with rhinitis in the pharmacy. A cross-sectional study in real life. Asthma Res Pract. doi:10.1186/s40733-015-0002-6.

  8. Baffi CW, Winnica DE, Holguin F. Asthma and Obesity: Mechanisms and Clinical Implications. Asthma Res Pract. doi:10.1186/s40733-015-0001-7.

    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

    Sign up to receive new article alerts from Asthma Research and Practice   

The following new articles have just been published in Asthma Research and Practice

Juan Carlos Ivancevich Wednesday, 10 June 2015 15:12

The following new articles have just been published in Asthma Research and Practice

For articles using Author Version-first publication you will see a provisional PDF corresponding to the accepted manuscript. In these instances, the fully formatted Final Version PDF and full text (HTML) versions will follow in due course.

Editorial   

Asthma research and practice: a new journey begins

Celedon J, Passalacqua G, Canonica G

Asthma Research and Practice 2015, 1 :5 (4 June 2015)

Abstract | Full Text | PDF

 

Research   

The patient with rhinitis in the pharmacy. A cross-sectional study in real life

Lombardi C, Musicco E, Rastrelli F, Bettoncelli G, Passalacqua G, Canonica G

Asthma Research and Practice 2015, 1 :4 (4 June 2015)

Abstract | Full Text | PDF

 

Research   

Vitamin D supplementation decreases Aspergillus fumigatus specific Th2 responses in CF patients with aspergillus sensitization: a phase one open-label study

Nguyen N, Pilewski J, Celedón J, Mandalapu S, Blanchard M, DeRicco A, Hartigan E, Alcorn J, Kolls J

Asthma Research and Practice 2015, 1 :3 (4 June 2015)

Abstract | Full Text | PDF

 

Review   

Asthma and obesity: mechanisms and clinical implications

Baffi C, Winnica D, Holguin F

Asthma Research and Practice 2015, 1 :1 (4 June 2015)

Abstract | Full Text | PDF

Welcome to Fernando Holguin

Juan Carlos Ivancevich Tuesday, 02 June 2015 15:24

Welcome to Fernando Holguin, new AE for journal Research & Practice:

Asthma Research and Practice

Juan Carlos Ivancevich Thursday, 07 May 2015 13:21
 
Editors-in-Chief
Juan C. Celedón  University of Pittsburgh, United States - Giovanni Passalacqua  University of Genoa, Italy
Founding Editor 
Carlos E Baena-Cagnani Catholic University of Cordoba, Argentina
About Asthma Research and Practice This page includes information about the aims and scope of Asthma Research and Practice, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.
Accepting submissions
 

Join our more than 1,000 followers on Twitter!

Juan Carlos Ivancevich Wednesday, 29 April 2015 18:22

Join our more than 1,000 followers on Twitter!

https://twitter.com/Interasma

Interasma on Twitter

Juan Carlos Ivancevich Friday, 24 April 2015 14:28

Interasma welcomes its first 1000 followers on Twitter: https://twitter.com/Interasma

World Allergy Week 2015

Juan Carlos Ivancevich Tuesday, 14 April 2015 13:35

World Allergy Week is an annual initiative of the World Allergy Organization (WAO), together with its Member Societies, to raise awareness of allergic disease and related disorders and advocate for the provision of training and resources in the diagnosis, management, and prevention of these diseases and asthma, which are rising in prevalence around the world.

WAO established the initiative with the vision of bringing together multiple stakeholder groups including physicians, medical educators, patient advocates, policy makers, the general public, and health care authorities for an integrated approach to addressing the needs of patients who suffer from allergic diseases and asthma and those who provide care for them.

Historically, WAO hosted “World Allergy Day," in association with the biennial World Allergy Congress, beginning with the first event in July 2005. After recommendations from WAO Member Societies and other associates of WAO to expand the scope and timeline of World Allergy Day so as to facilitate wider participation around the world, the WAO Board of Directors approved the establishment of World Allergy Week in 2011.

There are many ways to get involved. Each year WAO receives stories, audio and video recordings, photographs and press releases from the many programs and activities that take place locally, nationally and regionally due to the innovative planning of participating individuals and organizations. Many of these reports are archived on this website.

WAO provides resources every year regarding the global theme for its Member Societies and information for everyone interested in World Allergy Week. Follow the links below to learn more!

World Allergy Week 2015 Resources

Information for WAO Member Societies

Information for the Press

Patient Advocacy Organizations and Resources

WAO and Member Society Airway Allergy Online Resources

View Past Events

World Allergy Week 2014
World Allergy Week 2013
World Allergy Week 2012
World Allergy Week 2011

World Congress of Asthma 2016, Madrid - First Announcement & Call for Abstracts

Juan Carlos Ivancevich Wednesday, 08 April 2015 15:42
_________________________________
Please visit http://www.wca-2016.com/ 
XXIII World Congress of Asthma
WCA 2016 Madrid Spain
 
 
 
         

 

Interasma Symposia in the Latin American Congress of Allergy, Asthma & Immunology

Juan Carlos Ivancevich Tuesday, 17 March 2015 14:30
16/03/2015 - Panamericano Hotel & Convention Center, Buenos Aires, Argentina
 
Tribute tol Prof. Carlos E. Baena-Cagnani, INTERASMA Past President

Chairmen: Ignacio Ansotegui, Juan C. Ivancevich
 
11:15
Introduction: The Global Impact of Asthma
G Walter Canonica
11:35
Late Phase Response in Asthma
Louis P. Boulet
11:55
Inhalation Challenges in Occupational Asthma
Joaquin Sastre
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Prof. G. Walter Canonica: In memorian: a tribute to Carlos E. Baena-Cagnani in the Latin American Congress SLaai2015

Juan Carlos Ivancevich Sunday, 15 March 2015 04:02

Interasma on Twitter

Interasma RT @Aller_MD: Top story: Is it a food allergy? https://t.co/ESaWtExlry, see more https://t.co/jgCeENQuZt
4hreplyretweetfavorite
Interasma RT @Aller_MD: #Dupilumab (Dupixent) is known to help control atopic dermatitis by diminishing interleukin (IL)-13, but that same mechanism…
4hreplyretweetfavorite
Interasma RT @Aller_MD: “Nasal delivery of leptin hormone may help ease breathing problems during sleep” https://t.co/kPhCp7YbFw https://t.co/mNuyNkD
4hreplyretweetfavorite
Interasma RT @Aller_MD: The 'greying' of T cells: Scientists pinpoint metabolic pathway behind age-related immunity loss https://t.co/V2QIjHJPn1
4hreplyretweetfavorite
Interasma RT @Aller_MD: The latest Allergy, Asthma & Immunology! https://t.co/Thi7i4hPcI Thanks to @GoAllergy @CochraneAirways #eehealthchoices #immu
4hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma